Marker Therapeutics, Inc. (MRKR): Price and Financial Metrics
MRKR Price/Volume Stats
| Current price | $3.18 | 52-week high | $6.16 |
| Prev. close | $3.19 | 52-week low | $2.44 |
| Day low | $2.97 | Volume | 17,900 |
| Day high | $3.25 | Avg. volume | 25,576 |
| 50-day MA | $3.29 | Dividend yield | N/A |
| 200-day MA | $4.00 | Market Cap | 28.38M |
MRKR Stock Price Chart Interactive Chart >
Marker Therapeutics, Inc. (MRKR) Company Bio
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR Price Returns
| 1-mo | -29.96% |
| 3-mo | -13.23% |
| 6-mo | -23.19% |
| 1-year | 18.66% |
| 3-year | -74.35% |
| 5-year | -88.80% |
| YTD | -42.18% |
| 2023 | 106.84% |
| 2022 | -72.02% |
| 2021 | -34.47% |
| 2020 | -49.65% |
| 2019 | -48.11% |
Loading social stream, please wait...